These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1335308)
21. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Brownlie J; Clarke MC; Hooper LB; Bell GD Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232 [TBL] [Abstract][Full Text] [Related]
23. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus. Zimmer GM; Wentink GH; Bruschke C; Westenbrink FJ; Brinkhof J; de Goey I Vet Microbiol; 2002 Nov; 89(4):255-65. PubMed ID: 12383635 [TBL] [Abstract][Full Text] [Related]
24. Control of bovine viral diarrhea infection by use of vaccination. Bolin SR Vet Clin North Am Food Anim Pract; 1995 Nov; 11(3):615-25. PubMed ID: 8581866 [TBL] [Abstract][Full Text] [Related]
25. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela Platt R; Kesl L; Guidarini C; Wang C; Roth JA Vet Immunol Immunopathol; 2017 May; 187():20-27. PubMed ID: 28494925 [TBL] [Abstract][Full Text] [Related]
26. Diagnosis of natural exposure to bovine viral diarrhea in a vaccinated herd by measuring extended antibody titers against bovine viral diarrhea virus. Ross J Can Vet J; 2003 Jan; 44(1):59-61. PubMed ID: 12619558 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials. Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433 [TBL] [Abstract][Full Text] [Related]
28. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330 [TBL] [Abstract][Full Text] [Related]
29. [BVD approach: vaccination and eradication]. Verberne LR Tijdschr Diergeneeskd; 2000 Apr; 125(7):218-21. PubMed ID: 10775986 [TBL] [Abstract][Full Text] [Related]
30. Serological responses in calves to vaccines against bovine respiratory syncytial, infectious bovine rhinotracheitis, bovine viral diarrhoea and parainfluenza-3 viruses. Tollis M; Di Trani L; Cordioli P; Vignolo E; Di Pasquale I Dev Biol Stand; 1996; 86():147-56. PubMed ID: 8785944 [TBL] [Abstract][Full Text] [Related]
31. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep. Bruschke CJ; van Oirschot JT; van Rijn PA Vaccine; 1999 Apr; 17(15-16):1983-91. PubMed ID: 10217598 [TBL] [Abstract][Full Text] [Related]
33. Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: assessment of potential to differentiate infected and vaccinated animals. Raue R; Harmeyer SS; Nanjiani IA Vet J; 2011 Mar; 187(3):330-4. PubMed ID: 20074985 [TBL] [Abstract][Full Text] [Related]
34. BVDV vaccination in North America: risks versus benefits. Griebel PJ Anim Health Res Rev; 2015 Jun; 16(1):27-32. PubMed ID: 26050569 [TBL] [Abstract][Full Text] [Related]
35. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves. Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747 [TBL] [Abstract][Full Text] [Related]
36. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves. Peters AR; Thevasagayam SJ; Wiseman A; Salt JS Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335 [TBL] [Abstract][Full Text] [Related]
38. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Patel JR; Shilleto RW; Williams J; Alexander DC Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111 [TBL] [Abstract][Full Text] [Related]
39. Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny. Dehan P; Couvreur B; Hamers C; Lewalle P; Thiry E; Kerkhofs P; Pastoret PP Vaccine; 2005 Jul; 23(33):4236-46. PubMed ID: 16005739 [TBL] [Abstract][Full Text] [Related]
40. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves. Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]